Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ARK Invest: The Starlink business alone is sufficient to support SpaceX's nearly $2 trillion IPO valuation

ARK Invest: The Starlink business alone is sufficient to support SpaceX's nearly $2 trillion IPO valuation

BlockBeatsBlockBeats2026/06/04 14:29
Show original

BlockBeats reported on June 4 that, according to CNBC, Brett Winton, Chief Futurist at ARK Invest, stated that SpaceX's upcoming IPO could become one of the most important stock offerings in history, with its satellite internet business Starlink alone able to support a valuation close to 2 trillion dollars.


SpaceX has set the IPO price at 135 dollars per share and plans to list on Nasdaq on June 12, with a pre-listing valuation of around 1.77 trillion dollars. The company plans to sell 555.6 million shares, raising about 75 billion dollars, and underwriters can also purchase an additional 83.33 million shares at the IPO price, corresponding to about 11.2 billion dollars. After the IPO, Musk will hold over 82% of the voting control.


Winton said that SpaceX's growth prospects are not limited to launch services and are closely related to the rapid expansion of AI. ARK estimates that by 2030, the combined enterprise value of companies developing and operating foundational AI models could reach 15 trillion to 20 trillion dollars.


Winton noted that investors typically focus on SpaceX’s reusable rockets, but Starlink is the main driving factor in ARK’s valuation logic. He stated that Starlink’s current satellite constellation can provide about 500 Tbps of bandwidth and generate annual revenue of about 13 billion dollars. With the launch of the Starship rocket, SpaceX can significantly reduce launch costs and deploy more satellites at a faster pace.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Henry Schein shares fall after appointing new Chief Financial Officer

October 8 - ** Shares of dental products distributor Henry Schein (HSIC.O) dropped 2% to $82 in pre-market trading. ** Ronald South, who has served as CFO for the past four years, will transition to Senior Advisor. ** Emmanuel Caprais will take over as CFO, officially assuming the role on November 4. ** Caprais was previously the Chief Financial Officer of global industrial manufacturer ITT. ** This leadership change comes about seven months after Frederick Lowery succeeded Stanley Bergman as CEO; Bergman had led the company for 35 years. ** Among 18 brokers, 9 rate the stock as “buy” or above, 8 as “hold”, and 1 as “sell”; the median target price is $96—data compiled by LSEG. ** As of the previous trading day's close, the stock has risen 10.69% year-to-date.

路透社•2026/10/08 11:47

Movado to Sell 95% Stake in EBEL Luxury Watch Brand for $66.5 Million

07:34 AM EDT, 10/08/2026 (MT Newswires) -- Movado (MOV) said Thursday that it has agreed to sell a 95% stake in its EBEL luxury watch brand for $66.5 million to a group led by Montres Journe, with participation from Chanel and Pierre Jacques. The deal enables Movado to deepen its focus on its core luxury and fashion watch and jewelry products, it said. Movado said it will initially transfer EBEL's intellectual property, inventory, and certain other assets to a newly formed Swiss unit, while retaining a 5% stake in the business. The transaction, expected to close in the next few months, is subject to adjustments and closing conditions, the company said.

MT newswire•2026/10/08 11:34

Hydreight makes C$ 300,000 strategic investment in Insu Therapeutics

Hydreight Technologies disclosed a C$ 300,000 minority investment in Insu Therapeutics, completed on March 13, 2026. The deal also granted Hydreight U.S. distribution rights for peptide medicines using Insu’s buccal delivery technology, subject to development success. Insu received a USPTO Notice of Allowance on a buccal peptide-delivery patent application, reinforcing Hydreight’s strategic stake. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hydreight Technologies Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202610080730CANADANWCANADAPR_C0229) on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/08 11:31

BUZZ-KeyBanc upgrades Generac rating, boosted by Amazon deal, shares rise

On October 8th, after KeyBanc upgraded the rating of power equipment manufacturer Generac (GNRC.N) from "sector weight" to "overweight," Generac's stock price rose 1.2% in pre-market trading to $224. The brokerage stated that GNRC's data center power supply agreement with Amazon.com (AMZN.O) validates its position as a leading generator supplier. According to the brokerage, GNRC's management plans to achieve $3 billion to $3.2 billion in data center revenue by 2028 and remains confident in boosting supply chain capacity. KeyBanc also highlighted that, following multiple divestitures of portfolio assets, management continues to maintain a disciplined approach to capital allocation. As of the previous trading day's close, GNRC’s cumulative year-to-date gains exceeded 62%.

路透社•2026/10/08 11:16